IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 4618 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (231 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References

 Article Access Statistics
    Viewed1897    
    Printed33    
    Emailed0    
    PDF Downloaded54    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Year : 2016  |  Volume : 82  |  Issue : 3  |  Page : 306-307

Misinterpretation of ATP2C1 gene mutations


School of Pharmaceutical Science and Technology, Dalian University of Technology, Dalian 116024, China

Date of Web Publication6-Apr-2016

Correspondence Address:
Prof. Massimo Micaroni
School of Pharmaceutical Science and Technology, Dalian University of Technology, West Campus, No. 2 Linggong Road, Dalian 116024
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.175922

Rights and Permissions



How to cite this article:
Micaroni M. Misinterpretation of ATP2C1 gene mutations. Indian J Dermatol Venereol Leprol 2016;82:306-7

How to cite this URL:
Micaroni M. Misinterpretation of ATP2C1 gene mutations. Indian J Dermatol Venereol Leprol [serial online] 2016 [cited 2020 May 27];82:306-7. Available from: http://www.ijdvl.com/text.asp?2016/82/3/306/175922


Sir,

I have carefully read the manuscript of Tian et al., where the authors reported several mutations of the human ATP2C1 gene, six of which they claim to have been identified for the first time.[1] However, two of them have been reported previously.

Tian et al. reported as new “the aberrant splice mutation c.621 (-1A>G) in exon 3 of the ATP2C1 gene from the patient FHHD-3”.[1] However, the authors did not indicate any gene to properly address the reported mutation making proper localization of the reported mutation along the ATP2C1 gene difficult. Nevertheless, the coding region surrounding the mutation as reported in [Figure 1]e of Tian et al.[1] (TCT AAT AAG CTG ATC T; underlined is the mutated site), overlaps with the intron 2/exon 3 region of the ATP2C1 gene as reported previously by Sudbrak et al. [Table 1].[1],[2] Moreover, in a previous report, Fairclough et al. described a mutation (patient NC12, mutation 118 [−1G>A], aberrant splicing in intron 2) that is identical to that reported to be new by Tian et al. (patient FHHD-3, mutation 621 [−1A>G] aberrant splicing in exon 3).[1],[3]

In addition, two further mistakes may also be noticed in Tian et al's. paper.[1] First, the mutation reported by Tian et al. would be a single nucleotide substitution A>G on the last nucleotide of intron 2 and not of exon 3 as reported by Tian et al.[1] [see also [Table 1] in Fairclough et al.].[3] Second, the adenine at position-1 of the splice site of intron 2/exon 3 is present in the mutated sequence of the ATP2C1 gene, whereas guanine is in the original position and not vice versa as reported by Tian et al.[1],[2],[3] Thus, the mutation reported in the ATP2C1 gene in patient FHHD-3 is not new and has not been correctly reported (neither for corresponding nucleotide position (118, and not 621) nor nucleotide replacement [G>A and not A>G, is the correct mutation]).

Further analysis of the manuscript indicated some more inconsistencies. Tian et al. referring to the patient SHHD-5 described a new missense c. 666T>C in exon 3, generating a glycine in the place of arginine [R66G].[1] However, while glycine is coded by four codons (GGT, GGC, GGA, and GGG), the arginine is coded by six codons (CGT, CGC, CGA, CGG, AGA, and AGG). Therefore, what has been reported by Tian et al. may not be correct.[1] Besides, according to the reported mutation, if thymine was replaced with cytosine in the unique codon encoding for an arginine containing a thymine (CGT), one generates CGC which is still coding for an arginine. However, something interesting comes up if the correct reading frame of the ATP2C1 is considered [see [Table 1] in Sudbrak et al.].[2] The surrounding sequence of the ATP2C1 gene where the mutation c. 666T>C in patient SHHD-5 occurs [Figure 1]g in Tian et al.], presents the reading codon frame CAT AGG CGA GCC TTT (encoding for His-Arg-Arg-Ala-Phe, respectively; underlined is the mutation site).[1] First, the codon CGA, where the mutation is located, is codon 55 and not codon 66, as reported by Tian et al. (for the correct coding sequence, relative frame and corresponding amino acid sequence, see http://www.ncbi.nlm.nih.gov/nuccore/AF181120).[1] Second, in the mutation c. 666T>C, cytosine was replaced with thymine (and not 666T>C - which would have meant that thymine was replaced with a cytosine), which whould generate a TGA codon which is a STOP codon. The codon CGA could be mutated encoding for a glycine replacing thymine with cytosine. Furthermore, this mutation has been previously described.[4] Interestingly, the same team of authors of the manuscript reported this mutation in exon 13 instead of exon 3 (patient FHHD-8, c. 163C>T), indicating it as “recurrent” [Table 1].[1],[5]

Acknowledgment

I would like to thank Prof. Gary Xiao, Dalian University of Technology, Dalian, China, for supporting my research. Thanks to Dr. Seetharaman Parashuraman, TIGEM Institute, Naples, Italy and to Dr. Giuseppe Perinetti, University of Trieste, Italy, for critical reading of the manuscript.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Tian H, Chen M, You J, Fu X, Liu H, Shi Z, et al. Six novel mutations of ATP2C1 identified in eight Chinese patients with Hailey-Hailey disease. Indian J Dermatol Venereol Leprol 2013;79:245-7.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.
Sudbrak R, Brown J, Dobson-Stone C, Carter S, Ramser J, White J, et al. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca (2) pump. Hum Mol Genet 2000;9:1131-40.  Back to cited text no. 2
    
3.
Fairclough RJ, Lonie L, Van Baelen K, Haftek M, Munro CS, Burge SM, et al. Hailey-Hailey disease: Identification of novel mutations in ATP2C1 and effect of missense mutation A528P on protein expression levels. J Invest Dermatol 2004;123:67-71.  Back to cited text no. 3
    
4.
Zhang GL, Sun YT, Shi HJ, Gu Y, Shao MH, Du XF. Mutation analysis of ATP2C1 gene in a Chinese family with Hailey-Hailey disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2010;27:414-6.  Back to cited text no. 4
    
5.
Zhang HZ, Tian HQ, Du DH, Wang GJ, Yan XX, Liu H, et al. Analysis of ATP2C1 gene mutations in Chinese patients with Hailey-Hailey disease. Clin Exp Dermatol 2012;37:190-3.  Back to cited text no. 5
[PUBMED]    




 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow